Cargando…
Effects of Hypolipidemic Drugs on Psoriasis
Psoriasis is a chronic, systematic, inflammatory disease in which multiple metabolic and immunologic disturbances lead to lipid abnormalities, impaired glucose tolerance, metabolic syndrome, diabetes mellitus, atherosclerosis, hypertension, ischemic heart disease, and numerous metabolic disorders. I...
Autores principales: | Matwiejuk, Mateusz, Mysliwiec, Hanna, Jakubowicz-Zalewska, Olivia, Chabowski, Adrian, Flisiak, Iwona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142060/ https://www.ncbi.nlm.nih.gov/pubmed/37110152 http://dx.doi.org/10.3390/metabo13040493 |
Ejemplares similares
-
The Role of Sphingolipids in the Pathogenesis of Psoriasis
por: Matwiejuk, Mateusz, et al.
Publicado: (2022) -
Crosstalk between Serum and Skin Sphingolipids in Psoriasis
por: Matwiejuk, Mateusz, et al.
Publicado: (2023) -
The Interplay between Bioactive Sphingolipids in the Psoriatic Skin and the Severity of the Disease
por: Matwiejuk, Mateusz, et al.
Publicado: (2023) -
Serum fatty acid profile in psoriasis and its comorbidity
por: Myśliwiec, Hanna, et al.
Publicado: (2017) -
Serum fatty acid binding protein 5 (FABP5) as a potential biomarker of inflammation in psoriasis
por: Kozłowska, Dorota, et al.
Publicado: (2021)